We are live on ! Find out more
AlphaCentric Advisors

AlphaCentric Advisors Portfolio holdings

AUM $113M Turnover 27.4%
1-Year Est. Return 27.37%
This Fund
S&P 500
This Quarter Est. Return
-3.08%
1 Year Est. Return
+27.37%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$5.41M
Cap. Flow
+$2.01M
Cap. Flow %
1.79%
Top 10 Hldgs %
23.44%
Holding
292
New
33
Increased
148
Reduced
40
Closed
47
Avg Time Held
1.2 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.6 years

Sector Composition

Rank Sector Weight
1 Healthcare 44.1%
2 Miscellaneous 19.55%
3 Technology 9.14%
4 Industrials 8.04%
5 Real Estate 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALNY icon
101
Alnylam Pharmaceuticals
ALNY
$21.6B
$353K 0.31%
1,432
+42
+3% +$10.7K
2025 Q4
3 quarters
BEAM icon
102
Beam Therapeutics
BEAM
$2.27B
$350K 0.31%
+14,322
New +$399K
2026 Q3
0 quarters
TRAX icon
103
First Tracks Biotherapeutics
TRAX
$1.98B
$348K 0.31%
+9,821
New +$384K
2026 Q3
0 quarters
MNST icon
104
Monster Beverage
MNST
$89.8B
$335K 0.3%
8,060
+786
+11% +$36.4K
2026 Q1
2 quarters
CBOE icon
105
Cboe Global Markets
CBOE
$39.1B
$331K 0.29%
1,203
+120
+11% +$34K
2026 Q1
2 quarters
CGEM icon
106
Cullinan Therapeutics
CGEM
$647M
$327K 0.29%
21,278
+852
+4% +$16.3K
2025 Q4
3 quarters
VZ icon
107
Verizon
VZ
$193B
$322K 0.29%
7,009
+777
+12% +$36.6K
2024 Q4
7 quarters
GLUE icon
108
Monte Rosa Therapeutics
GLUE
$796M
$320K 0.28%
26,802
+14,157
+112% +$243K
2026 Q1
2 quarters
ANNX icon
109
Annexon
ANNX
$712M
$319K 0.28%
75,495
+50,623
+204% +$254K
2026 Q1
2 quarters
RZLT icon
110
Rezolute
RZLT
$350M
$313K 0.28%
75,495
+3,240
+4% +$14.9K
2025 Q4
3 quarters
MGM icon
111
MGM Resorts International
MGM
$8.46B
$310K 0.28%
+10,000
New +$427K
2026 Q3
0 quarters
ARWR icon
112
Arrowhead Research
ARWR
$6.45B
$300K 0.27%
+4,587
New +$371K
2026 Q3
0 quarters
MBOT icon
113
Microbot Medical
MBOT
$42.9M
$300K 0.27%
250,000
– –
2020 Q2
25 quarters
GD icon
114
General Dynamics
GD
$97.3B
$296K 0.26%
892
+91
+11% +$33.8K
2026 Q1
2 quarters
HYGV icon
115
Northern Trust High Yield Value-Scored Bond ETF
HYGV
$1.01B
$291K 0.26%
7,483
-718
-9% -$28.7K
2023 Q2
13 quarters
JNK icon
116
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.33B
$290K 0.26%
3,132
-292
-9% -$27.8K
2023 Q2
13 quarters
ANGI icon
117
Angi
ANGI
$258M
$288K 0.26%
50,000
– –
2026 Q1
2 quarters
WELL icon
118
Welltower
WELL
$180B
$284K 0.25%
+1,232
New +$291K
2026 Q3
0 quarters
DSGN icon
119
Design Therapeutics
DSGN
$650M
$283K 0.25%
22,505
+968
+4% +$13.4K
2025 Q4
3 quarters
IVZ icon
120
Invesco
IVZ
$12.5B
$281K 0.25%
9,326
-7,157
-43% -$220K
2025 Q4
3 quarters
UHS icon
121
Universal Health Services
UHS
$11.3B
$280K 0.25%
1,606
+939
+141% +$157K
2024 Q2
9 quarters
ALL icon
122
Allstate
ALL
$66.9B
$276K 0.25%
1,245
+588
+89% +$149K
2024 Q2
9 quarters
STT icon
123
State Street
STT
$46.4B
$276K 0.24%
+1,578
New +$292K
2026 Q3
0 quarters
HST icon
124
Host Hotels & Resorts
HST
$17.5B
$275K 0.24%
+12,266
New +$283K
2026 Q3
0 quarters
CSX icon
125
CSX
CSX
$96.5B
$268K 0.24%
+5,770
New +$286K
2026 Q3
0 quarters

Similar funds

AlphaCentric Advisors's Q3 2026 Portfolio in Review

As of Q3 2026, AlphaCentric Advisors held 292 positions worth $113M, down 4.6% from $118M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

AlphaCentric Advisors's Q3 2026 filing shows 33 new, 148 increased, 40 reduced and 47 closed positions. Its largest new stake was Alpine Income Property Trust: 75,000 shares worth $1.3M. The largest sale was Apogee Therapeutics, an estimated $1.53M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 44% a quarter earlier, followed by Miscellaneous and Technology.

  • AlphaCentric Advisors's largest Q3 2026 buy was Alpine Income Property Trust: 75,000 shares worth $1.3M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q3 2026, an estimated $4.34M increase.
  • AlphaCentric Advisors's biggest Q3 2026 reduction was Graphic Packaging, cutting an estimated $428K.
  • AlphaCentric Advisors fully exited Apogee Therapeutics in Q3 2026, selling an estimated $1.53M.
  • AlphaCentric Advisors's ten largest holdings make up 23% of its $113M portfolio in Q3 2026.
  • AlphaCentric Advisors opened 33 new positions and closed 47 in Q3 2026.
  • AlphaCentric Advisors's portfolio value fell 4.6% quarter-over-quarter to $113M.

Based on AlphaCentric Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.